Helicobacter pylori: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

844

Figures (1-2)

129

Tables (1-3)

141

Sum=1149

Publishing Process of This Article

Item

Count

Browse

Download

Sum=66

Jun 6, 2024 (publication date) through Jan 25, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Cases. Jun 6, 2024; 12(16): 2773-2779
Published online Jun 6, 2024. doi: 10.12998/wjcc.v12.i16.2773

Table 3 Breakdown of non treatment-naive cohort by prior therapy and eradication status

CTT: Clarithromycin triple therapy; LTT: Levofloxacin triple therapy; MTT: Metronidazole triple therapy; BQT: Bismuth triple therapy.

Citation: Costigan C, O'Sullivan AM, O'Connell J, Sengupta S, Butler T, Molloy S, O'Hara FJ, Ryan B, Breslin N, O'Donnell S, O'Connor A, Smith S, McNamara D. Helicobacter pylori: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort. World J Clin Cases 2024; 12(16): 2773-2779
URL: https://www.wjgnet.com/2307-8960/full/v12/i16/2773.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i16.2773